News Author: Sara Freeman Publish date: November 10, 2015
Key clinical point: Metformin could improve responses to radiation therapy but data are hypothesis generating at this stage.
Major finding: Improv...
News Author: Sara Freeman Publish date: November 9, 2015
Key clinical point: Stereotactic body radiation therapy used with a novel tumor cell vaccine and a dose-modified FOLFIRINOX regimen represents a n...
News Author: Sara Freeman Publish date: November 6, 2015
News Author: Sara Freeman Publish date: November 4, 2015
News Author: Sara Freeman Publish date: November 3, 2015
Key clinical point: ADT continued for 2 years is associated with significantly better outcomes than stopping at 4 months in men with localized pro...
News Author: Sara Freeman Publish date: November 1, 2015
Key clinical point: Some patients with metastatic melanoma may benefit from combined use of novel immunotherapies and radiation treatment.
News Author: Sara Freeman Publish date: October 31, 2015
Patients who have low-risk human papillomavirus (HPV)–associated oropharyngeal cancers may be effectively and safely treated with a reduced intensity ...
News Author: Sara Freeman Publish date: October 29, 2015
Key clinical point:Accelerated partial breast irradiation (APBI) was as effective as whole breast irradiation (WBI) plus a boost in preventing loc...
News Author: Sara Freeman Publish date: October 28, 2015
Key clinical point:Pain flares associated with radiotherapy for bone metastases could be managed by giving dexamethasone.
Major finding: Fewer pat...
News Author: Sara Freeman Publish date: October 27, 2015
Key clinical point: As the air temperature gets progressively lower, the STEMI risk increases.
Major finding: The STEMI event rate was 0.94 per da...
News Author: Sara Freeman Publish date: October 21, 2015
Results of several trials and analyses, some presented for the first time, at the annual meeting of the European Association for the Study of Diabetes...
News Author: Sara Freeman Publish date: October 21, 2015
Key clinical point: PEGlispro showed superior glycemic control when compared with glargine, with relatively good tolerability and cardiovascular s...
News Author: Sara Freeman Publish date: October 19, 2015
Evolocumab, used in addition to the standard of care, lowered LDL-C and improved other lipid parameters in people with type 2 diabetes just as effecti...
News Author: Sara Freeman Publish date: October 18, 2015
Key clinical point: Better monitoring and management of both hypertension and depression could help reduce further cardiovascular morbidity and mo...
News Author: Sara Freeman Publish date: October 15, 2015
Key clinical point: Air pollution may be a potentially modifiable risk factor for STEMI in men.
